Study of the use of antipsychotic drugs in the manuel piti fajardo psychiatric hospital in Manzanillo

Authors

Keywords:

Prescription patterns, Antipsychotic, Schizophrenia.

Abstract

An observational, descriptive, longitudinal and retrospective study of the prescription-indication type and quantitative study of consumption was carried out, with the aim of identifying the patterns of prescription of antipsychotics in patients with a diagnosis of schizophrenia and related disorders hospitalized at the Manuel Piti Fajardo Psychiatric Hospital of Manzanillo in the period from January 2013 to January 2015. The data were obtained from medical records. Most of the patients were in the 18 to 40 year age range, female, and single. A higher percentage had a time of illness greater than five years, a hospital stay greater than one month, and had no previous hospitalizations. The most frequent diagnosis was schizophrenia. A small group of patients presented some psychiatric comorbidity, such as depressive disorder. The most widely used antipsychotic, either as monotherapy or in combination with another antipsychotic, was chlorpromazine. In general, these drugs were used within the therapeutic range, with a good response to treatment; the adverse drug reactions that occurred were mainly extrapyramidal disorders and sedation; the association of antipsychotics with central nervous system depressants was the most frequent potential drug interaction.

Downloads

Download data is not yet available.

References

1. Urquía Ml. Teorías dominantes y alternativas en epidemiología. 2ª ed [Internet]. Buenos Aires: EDUNLa Cooperativa; 2019 [citado 13/10/2020]. Disponible en: http://capacitasalud.com/wp-content/uploads/2019/02/Teorias-dominantes-y-alternativas-de-la-epidemiologia.pdf

2. Bojórquez Giraldo E, Arévalo Alván A, Castro Cisneros K, Ludowieg Casinelli L, Orihuela Fernández S. Patrones de prescripción de psicofármacos en pacientes con esquizofrenia y trastornos relacionados internados en el Hospital Víctor Larco Herrera, 2015. An Facmed. 2017; 78(4):386-92.

3. Coughlin M, Goldie CL, Tranmer J, Khalid-Khan S, Tregunno D. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics. Can J Psychiatry. 2018; 63(4):240-9.

4. Urban AE, Cubała WJ. Therapeutic drug monitoring of atypical antipsychotics. Psychiatr Pol. 2017;51(6):1059-77.

5. Chile. Ministerio de Salud. Guía Clínica AUGE: tratamiento de personas desde el primer episodio de Esquizofrenia. 3.ed [Internet]. Santiago de Chile: MINSAL; 2017 [citado 13/10/2020]. Disponible en: https://diprece.minsal.cl/wrdprss_minsal/wp-content/uploads/2017/07/GPC_EQZ.pdf

6. Galling B, Roldán A, Hagi K, Rietschel L, Walyzada F, Zheng W, et al. Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regressionanalysis. World Psychiatry. 2017; 16(1):77–89.

7. Arango C, Baeza I, Bernardo M, Cañas F, Dios C de, Díaz Marsá M, et al. Antipsicóticos inyectables de liberación prolongada para el tratamiento de la esquizofrenia en España. Rev Psiquiatr Salud Ment (Barc.) 2018; 16(1):11-28.

8. Millet Rodrígueza PE, Blanco Colungab CJ. Necesidades de rehabilitación cognitiva en sujetos esquizofrénicos. Rev. hosp. psiq. hab. 2019; 16(1):11-28.

9. Figueroa Calderón RI, Navarro Prada EL. Estudio de utilización de medicamentos antipsicóticos en combinación, para manejo de la esquizofrenia tipo paranoide en pacientes hombres del servicio de hospitalización de Psiquiatría General del hospital nacional Edgardo Rebagliati Martins. [Tesis]. Lima, Perú: Universidad Nacional Mayor de San Marcos; 2016. [citado 13/10/2020]. Disponible en: https://cybertesis.unmsm.edu.pe/bitstream/handle/20.500.12672/4681/Figueroa_cr.pdf?sequence=3&isAllowed=y

10. González Pando D. Química interpersonal o Neuroquímica; ¿enfermeras de salud mental o antipsicóticos depot? Presencia. 2018; 14: e11922.

11. Hilal Dandan R, Brunton LL. Manual de Farmacología y terapéutica. 2ª ed. México D.F: McGRAW-HILL INTERAMERICANA EDITORES, S.A; 2015.

12. Sönmez N, Røssberg JI, Evensen J, Eidsmo Barder H, Haahr U, Ten Velden W, et al. Depressive symptoms in first-episode psychosis: a 10-year follow-up study. Early Intervention in Psychiatry. 2016; 10(3): 227-33.

13. Fundación Instituto Catalá de Farmacología. Antipsicóticos: mala ciencia, pseudo-innovación, prescripción desbordada y iatrogenia. Butlletí Groc. 2016; 29(3-4):5-9.

14. Taylor DM, Barnes TR, Young AH. The Maudsley Prescribing Guidelines in Psychiatry. 13th ed. [Internet]. Pondicherry: WILEY Blackwell; 2018 [citado 13/10/2020]. Disponible en: https://dl.uswr.ac.ir/bitstream/Hannan/32636/1/9781119442608.pdf

15. Medina Guamán ME, Paucar Paccha MP. Prevalencia de pacientes esquizofrenicos no adherentes al tratamiento farmacologico y factores asociados del centro Humberto Ugalde Camacho. 2015-2016 [Tesis]. Cuenca: Universidad de Cuenca; 2017 [citado 13/10/2020]. Disponible en: http://dspace.ucuenca.edu.ec/bitstream/123456789/28785/1/PROYECTO%20DE%20INVESTIGACI%c3%93N.pdf

Published

2022-11-23

How to Cite

1.
Castillo Pérez L, Ortiz Sánchez Y, Saumell del Castillo LL, Grant Gómez KC, Gondres Barreiro Y. Study of the use of antipsychotic drugs in the manuel piti fajardo psychiatric hospital in Manzanillo. RM [Internet]. 2022 Nov. 23 [cited 2025 Sep. 7];26(5):e2156. Available from: https://revmultimed.sld.cu/index.php/mtm/article/view/2156

Issue

Section

ARTÍCULOS ORIGINALES